KALVISTA PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.3 USD | +0.09% |
|
-4.88% | -7.76% |
| 22/05 | Kalvista Pharmaceuticals Insider Sold Shares Worth $258,337, According to a Recent SEC Filing | MT |
| 22/04 | Kalvista Pharmaceuticals, Inc. Appoints William C. Fairey to the Board of Directors | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 477M | - | - | - | - | - | |
| 90.02B | ||||||
| 39.15B | ||||||
| 31.71B | ||||||
| 26.47B | ||||||
| 14.34B |
